1, Molecular imaging biomarkers for early diagnosis of Alzheimer's disease
The new brain imaging mixture, called AV-45, can quickly detect the early stages of brain damage in Alzheimer's patients and is expected to become the ruler of the disease.
2. Metastatic melanoma-targeting T-cell antibodies
The new anti-cancer drug ipilimumab can improve the autoimmune system more effectively against cancer. Studies have shown that ipilimumab can increase the survival rate of patients with advanced melanoma who were previously treated. The FDA is currently prioritizing the evaluation of this drug.
3, FDA approved first cancer vaccine
Provenge (Sipuleucel-T) is the first cancer vaccine that is good for survival and it stimulates the immune system to treat prostate cancer. Approval in April 2010 means that the drug can be used as soon as possible for the treatment of disease progression.
4. Jupiter Research: The Effect of Statins on Healthy Individuals
Through a large number of international studies, researchers found that cholesterol-lowering statin drugs can significantly reduce the risk of death from heart disease and normal cholesterol levels, but at the same time can cause inflammation.
5, Hepatitis C protease inhibitors
Boceprevir and telaprevir are awaiting approval. Both drugs target Hepatitis C virus and can rapidly improve the cure rate of current drugs.
6. Long-distance medical monitoring of patients with heart failure
Implantable micro-permanent monitors can monitor and communicate daily pulmonary artery pressure, just like household devices, by closely recording and transmitting weight, blood pressure, and heart rate data, with the potential to reduce the chance of hospitalization.
7, endoscopic non-incision gastric shaping weight loss
Endoscopic non-incisive gastroplasty (TOGA) is a surgical procedure that requires no incision for weight loss. The TOGA uses two flexible endoscopes to operate the instruments through the mouth to reduce the volume of the stomach.
8, exhaled nitrous oxide can diagnose asthma
A hand-held diagnostic test device accurately and accurately diagnoses asthma. This device diagnoses by measuring the level of nitrous oxide released by cells when the lungs are exhaled.
9, the first oral medication for multiple sclerosis treatment
Fingolimod has been approved by the FDA to treat the first oral drug for multiple sclerosis, the main breakthrough is clinical trials show that this drug can reduce the onset of disease and brain damage.
10, capsule endoscopy diagnosis of pediatric gastrointestinal diseases
A safe, pain-free pill-sized capsule with endoscopic imaging and X-ray imaging can take hundreds of photos and short-term video recordings in the digestive tract. The information can be sent to the data logger during operation.
Intermediates of Cladribine, Carvedilol, Lurasidone, olmesartan, Risedronate Sodium, Atazanavir, Saxagliptin, Dabigatran,Dapoxetine,Cefixime,Ceftaroline fosamil and etc.
In the short span of time, we have emerged as most promising pharmaceutical intermediates manufacturers, chemical intermediates and bulk drug intermediates suppliers. Our consistent supply, quality products and dedication towards clients have opened up many international avenues for our growth.
In addition, the company also can follow the customer's product needs custom synthesis services
MAIN API PRODUCTS USP/BP
PRODUCT NAME |
CAS NUMBER |
SPEVIFICATION |
Azithromycin |
117772-70-0 |
BEP |
Cefpirome Sulphate sterile |
84957-29-9 |
USP JP16 |
Ceftriaxone Sodium (Sterile) |
104376-79-6 |
USP31 |
Cefotaxime |
64485-93-4 |
USP30 |
Ciprofloxacin HCL |
85721-33-1 |
USP/BP |
Gentamicin sulphate |
1405-41-0 |
BP |
Levofloxacin |
100986-85-4 |
USP27 |
Lincomycin Hydrochloride |
859-18-7 |
EP6.0 |
Moxifloxacin Hydrochloride |
186826-86-8 |
USP31 |
Tigecycline |
220620-09-7 |
USP |
Linezolid |
165800-03-3 |
EP |
Dexamethasone |
50-02-2 |
USP/BP/EP |
Methylprednisolone |
83-43-2 |
USP/BP/EP |
Dexketoprofen trometamol |
156604-79-4 |
BP2008 |
Ibuprofen |
15687-27-1 |
BP |
Metamizol |
68-89-3 |
DAB |
Sulindac |
38194-50-2 |
USP/BP/EP |
Naproxcinod |
163133-43-5 |
USP28 |
Tripelennamine Hydrochloride |
154-69-8 |
USP28 |
Itraconazole |
84625-61-6 |
USP/BP |
Cytarabine |
147-94-4 |
USP31 |
Leucovorin Calcium |
1492-18-8 |
USP32 |
Valsartan |
137862-53-4 |
USP30 |
Telmisartan |
144701-48-4 |
USP31 |
Rosuvastatin Calcium |
147098-20-2 |
USP/BP |
Pitavastatin Calcium |
147526-32-7 |
USP/BP |
Fluvastatin |
93957-54-1 |
USP31 |
Vinpocetine |
42971-09-5 |
EP6.0 |
Atazanavir |
198904-31-3 |
BP |
Rosiglitazone |
122320-73-4 |
USP30 |
Esomeprazole Magnesium |
161973-10-0 |
USP/BP |
Topiramate |
97240-79-4 |
USP31 |
Fexofenadine HCl |
153439-40-8 |
Inhouse |
Bosentan |
147536-97-8 |
Inhouse |
D-Cysteine |
921-01-7 |
Inhouse |
D-Phenylalanine |
673-06-3 |
Inhouse |
Linagliptin |
668270-12-0 |
Inhouse |
Rivaroxaban |
366789-02-8 |
USP |
Saxagliptin |
361442-04-8 |
USP |
Vildagliptin |
274901-16-5 |
USP |
Major Pharmaceutical Intermediates
Items Descripation | Structure | Application |
MICA ESTER CAS No: 246035-38-1 Purity: ≥98% |
![]() |
For Cefixime |
EHATA CAS No: 64485-82-1 Purity: ≥98% |
![]() |
For Ceftazidine |
2-Chloroadenine CAS No: 1839-18-5 |
![]() |
For Cladribine, Fludarabine et al |
Bicyclo(2,2,1)Heptane-2,3-di-exo-carboximide CAS No: 14805o-29-9 |
![]() |
For Lurasidne |
(R,R)-1,2-Bis(methanesulfonyloxy methyl)Cyclohexane CAS No: 186204-35-3 |
![]() |
For Lurasidone |
3-(Piperazin-1-yl)benzol[d] isothiazole CAS No: 87691-87-0 |
![]() |
For Lurasidone |
Trityl olmesartan CAS No: 144690-92-6 Purity: ≥98% |
![]() |
For olmesartan |
3-Acetyl Pyridine CAS No: 350-03-8 |
![]() |
For Risedronate Sodium |
3-(AceticAcid)pyridine HCL CAS No: 6419-36-9 |
![]() |
For Risedronate Sodium |
Risedronic Acid CAS No: 105462-24-6 |
![]() |
For Risedronate Sodium |
3-Hydroxy-1-adamantyl-D-Glycine CAS No: 709031-29-8 |
![]() |
For Saxagliptin |
(1s,3s,5s)-3-(aminocarbonyl)-2-azabicyclo(3,1,0) hexane-2-carboxylic acid tert-butyl ester CAS No: 361440-67-7 |
![]() |
For Saxagliptin |
(S)-N-Boc-3- hydroxy-adamantylglycine CAS No: 361442-00-4 |
![]() |
For Saxagliptin |
2-Azabicyclo[3.1.0] hexane-3-carbonitrile, (1s,3s,5s)- CAS No: 866083-42-3 |
![]() |
For Saxagliptin |
Ethyl 3-(pyridin-2-ylamino) propanoate CAS No: 103041-38-9 |
![]() |
For Dabigatran |
N-(4-Cyanophenyl) glycine CAS No: 42288-26-6 |
![]() |
For Dabigatran |
4-methylamino-3-nitrobenzoic Acid CAS No: 41263-74-5 |
![]() |
For Dabigatran |
S-3-Amino-3-phenylpropanoic acid ethyl ester HCL CAS No: 167834-24-4 |
![]() |
For Dapoxetine |
(S)-3-Amino-3-Phemylpropan -1-ol CAS No: 82769-76-4 |
![]() |
For Dapoxetine |
(S)-3-Dimethylamino-3-Phemylpropanol CAS No: 82769-75-3 |
![]() |
For Dapoxetine |
4-{4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-butynil}-α,α-dimethyl benzene acetic acid CAS No: 832088-68-3 |
For Fexofenadine HCl | |
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate CAS No:154477-54-0 |
![]() |
For Fexofenadine HCl |
5-Bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone CAS No 461432-22-4 |
![]() |
For Dapagliflozin |
4-(5-Bromo-2-chlorobenzyl)phenyl ethyl ether CAS No :461432-23-5 |
![]() |
For Dapagliflozin |
Mica Ester,Pharma Intermediates,Ciprofloxacin Hcl Uses,Active Pharmaceutical Ingredients
NINGBO VOICE BIOCHEMIC CO. LTD , https://www.pharma-voice.com